USFDA Approves ImmunityBio Bladder Cancer Therapy
The United States Food and Drug Administration (USFDA) has approved ImmunityBio’s combination therapy to treat a type of bladder cancer.
ImmunityBio | 24/04/2024 | By Aishwarya | 207
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy